Arke Estudios Clinicos SA de CV

Veracruz 91910

0 studies enrolling now · 4 studies all time

What they study most

Atopic Dermatitis, Plaque Psoriasis, Type 2 Diabetes, Venous Thromboembolism

Studies at this site

• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes — Completed
• Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis — Completed
• RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism — Completed